Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283957
Max Phase: Preclinical
Molecular Formula: C26H30N6O8S2Se
Molecular Weight: 697.65
Associated Items:
ID: ALA5283957
Max Phase: Preclinical
Molecular Formula: C26H30N6O8S2Se
Molecular Weight: 697.65
Associated Items:
Canonical SMILES: NC(CCC(=O)NC(CS[Se]Cc1cc(-c2ccccc2)n(-c2ccc(S(N)(=O)=O)cc2)n1)C(=O)NCC(=O)O)C(=O)O
Standard InChI: InChI=1S/C26H30N6O8S2Se/c27-20(26(37)38)10-11-23(33)30-21(25(36)29-13-24(34)35)14-41-43-15-17-12-22(16-4-2-1-3-5-16)32(31-17)18-6-8-19(9-7-18)42(28,39)40/h1-9,12,20-21H,10-11,13-15,27H2,(H,29,36)(H,30,33)(H,34,35)(H,37,38)(H2,28,39,40)
Standard InChI Key: XFXHQMFXTQXSJC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 697.65 | Molecular Weight (Monoisotopic): 698.0732 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chuai H, Zhang SQ, Bai H, Li J, Wang Y, Sun J, Wen E, Zhang J, Xin M.. (2021) Small molecule selenium-containing compounds: Recent development and therapeutic applications., 223 [PMID:34217061] [10.1016/j.ejmech.2021.113621] |
Source(1):